Assoc Dir, Health Systems Medical Outcomes Science Liaison (Southeast)

Field-based scientific expert serving as Alnylam's primary medical liaison within integrated delivery networks (IDNs), academic health systems, and organized healthcare entities. Engages formulary decision makers, C-suite healthcare leaders, clinical pharmacists, and broader clinical leaders to provide balanced, evidence-based scientific and health economic information supporting informed formulary, access, and clinical pathway decisions, while identifying collaborative research opportunities.

Responsibilities

• Engage and build peer-level relationships with formulary decision makers, C-suite healthcare leaders, clinical pharmacists, pharmacy directors, and key clinical leaders who influence formulary decisions within IDNs and health systems.
• Conduct balanced, evidence-based scientific exchange to address data needs, gather insights, and communicate the clinical and economic value of Alnylam's portfolio.
• Develop account-specific strategic plans in collaboration with the Health System Director (HSD), including detailed assessment of key influencers and decision makers.
• Collect and share evidence gaps and insights to inform Alnylam's Value, Evidence, and Strategy (VESt) Team and advance meaningful data generation.
• Engage health system stakeholders in evidence-based scientific and outcomes-focused dialogue, using relevant clinical and health economic data to support awareness of diagnostic and treatment considerations at the system level.
• Identify scientific research collaboration opportunities, including real-world evidence generation, by leveraging internal stakeholders (Medical Affairs, Value & Access, VESt).
• Provide HEOR and outcomes data to support formulary review processes, clinical pathway development, and health system value assessments.
• Support regional and national IDN/healthcare systems congresses as needed.
• Collaborate closely with MSL colleagues to ensure integrated territory-level scientific strategy across clinical and system-level stakeholders.
• Maintain a thorough understanding of compliance requirements and applicable PhRMA Codes, OIG guidelines, FDA laws, and Alnylam's policies.
• Apply business acumen to prioritize health system engagements that maximize scientific impact and access for patients.
• Independently and proactively apply strategic thinking, scientific expertise, engagement excellence, integrity-driven conduct, and cross-functional collaboration within the health system to drive strong execution and continuous improvement.

Requirements

• Advanced degree: MD, DO, PharmD, or PhD in a relevant life science discipline. HEOR fellowship, MS, MBA, or MPH is a plus.
• 5+ years of Medical Affairs experience in pharmaceutical or biotech; prior field-based experience working directly with health systems or IDNs strongly preferred. Experience with federal health systems (VA, DoD) is a plus.
• Demonstrated understanding of pharmacoeconomic and health outcomes research principles.
• Solid working knowledge of US healthcare ecosystems, IDN structure, and formulary decision-making processes.
• Strong therapeutic area knowledge; rare disease experience preferred.
• Solid working knowledge of regulatory and compliance environment including PhRMA, OIG, and FDA guidelines.
• Excellent written and verbal communication skills; ability to engage diverse audiences from clinical staff to C-suite system leaders.
• Ability to travel up to 75%; must reside within assigned territory. Valid driver's license required.

Pay

U.S. pay range: $187,700.00 - $253,900.00 (full-time base salary at time of posting). Base pay determined by relevant experience, skills, and education. Eligible for annual short-term incentive award (e.g., bonus or sales incentive) and annual long-term incentive award (e.g., equity).

Benefits

• Comprehensive medical, dental, and vision coverage.
• Life and disability insurance.
• Lifestyle reimbursement program.
• Flexible spending and health savings accounts.
• 401(k) with generous company match.
• Paid time off, wellness days, holidays, and two company-wide recharge breaks.
• Generous family resources and leave.

About Alnylam

Leader in RNAi therapeutics, a revolutionary approach with the potential to transform lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered breakthroughs enabling RNAi therapeutics. The deep pipeline, late-stage programs, and bold vision reflect core values: fierce innovation, passion for excellence, purposeful urgency, open culture, and commitment to people. Recognized as a top global employer with an authentic, inclusive culture fueling breakthrough thinking.